Technical Presentation: Engineering of the New Breast Cancer Biomarker TestTechnical Presentation:
Abstract Cancer is most effectively treated when it is detected at an early stage. Unfortunately, many people do not have their cancer detected early. Reasons for this include technology limitations, reduced screening program participation, and gaps in access to screening. Blood tests are a type of technology with the potential to address cancer screening gaps. Traditional blood tests have not achieved the performance needed to detect early-stage cancer. Many blood test technologies are in various stages of research and development
